KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) Net Margin (2016 - 2025)

Elevance Health (ELV) has disclosed Net Margin for 16 consecutive years, with 7.82% as the latest value for Q2 2025.

  • On a quarterly basis, Net Margin rose 81397.0% to 7.82% in Q2 2025 year-over-year; TTM through Dec 2025 was 3.11%, a 1056.0% decrease, with the full-year FY2024 number at 3.37%, down 12.0% from a year prior.
  • Net Margin was 7.82% for Q2 2025 at Elevance Health, down from 0.75% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 6.31% in Q2 2021 to a low of 821.79% in Q2 2024.
  • A 5-year average of 56.12% and a median of 2.67% in 2022 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: crashed -82686bps in 2024, then skyrocketed 81397bps in 2025.
  • Elevance Health's Net Margin stood at 104.46% in 2021, then soared by 102bps to 2.28% in 2022, then fell by -16bps to 1.91% in 2023, then crashed by -6471bps to 121.47% in 2024, then surged by 94bps to 7.82% in 2025.
  • Per Business Quant, the three most recent readings for ELV's Net Margin are 7.82% (Q2 2025), 0.75% (Q1 2025), and 121.47% (Q4 2024).